Crossmark

Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction

Crossref DOI link: https://doi.org/10.1038/S41598-018-31832-5

Published: 2018-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Miranda, Jezid

Simões, Rui V.

Paules, Cristina

Cañueto, Daniel http://orcid.org/0000-0003-2948-0127
Pardo-Cea, Miguel A.

García-Martín, María L. http://orcid.org/0000-0002-2257-7682
Crovetto, Francesca

Fuertes-Martin, Rocio http://orcid.org/0000-0002-1558-8535
Domenech, Monica

Gómez-Roig, María D.

Eixarch, Elisenda

Estruch, Ramon

Hansson, Stefan R.

Amigó, Nuria

Cañellas, Nicolau

Crispi, Fatima

Gratacós, Eduard
License Information

Text and Data Mining valid from 2018-09-11
More Information

Article History

Received: 24 April 2018

Accepted: 13 August 2018

First Online: 11 September 2018

Competing Interests

: N. Amigó is stockowner of Biosfer Teslab and has a patent for the NMR method used for lipoprotein characterization. The rest of the authors report no conflict of interest.